BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12154380)

  • 1. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Cavazzana-Calvo M
    Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy of severe combined immunodeficiencies.
    Cavazzana-Calvo M; Hacein-Bey S; Yates F; de Villartay JP; Le Deist F; Fischer A
    J Gene Med; 2001; 3(3):201-6. PubMed ID: 11437325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene therapy for hereditary immunodeficiencies].
    Fischer A; de Saint-Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
    C R Seances Soc Biol Fil; 1996; 190(1):77-93. PubMed ID: 8881271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of primary immunodeficiencies.
    Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
    Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
    Fischer A; Le Deist F; Hacein-Bey-Abina S; André-Schmutz I; Basile Gde S; de Villartay JP; Cavazzana-Calvo M
    Immunol Rev; 2005 Feb; 203():98-109. PubMed ID: 15661024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMO2 and gene therapy for severe combined immunodeficiency.
    Stone BD
    N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15195349
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
    Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
    Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency.
    Gaspar HB; Howe S; Thrasher AJ
    Gene Ther; 2003 Nov; 10(24):1999-2004. PubMed ID: 14566358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for severe combined immune deficiency.
    Qasim W; Gaspar HB; Thrasher AJ
    Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy of severe combined immunodeficiencies: from mice to humans.
    Hacein-Bey S; Yates F; de Villartay JP; Fischer A; Cavazzana-Calvo M
    Neth J Med; 2002 Aug; 60(7):299-301. PubMed ID: 12430581
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrovirus mediated gene transfer as therapy for adenosine deaminase (ADA) deficiency.
    Ramsey WJ; Mullen CA; Blaese RM
    Leukemia; 1995 Oct; 9 Suppl 1():S70. PubMed ID: 7475319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for inherited immunodeficiencies.
    Howe S; Thrasher AJ
    Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies.
    Toscano MG; Frecha C; Ortega C; Santamaría M; Martín F; Molina IJ
    Gene Ther; 2004 Jun; 11(12):956-61. PubMed ID: 15029233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy.
    Culver KW
    J Insur Med; 1996; 28(2):121-4. PubMed ID: 10163946
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene therapy in recovery phase.
    Ready T
    Nat Med; 2002 May; 8(5):429-30. PubMed ID: 11984571
    [No Abstract]   [Full Text] [Related]  

  • 17. Visible integration of the adenosine deaminase (ADA) gene into the recipient genome after gene therapy.
    Egashira M; Ariga T; Kawamura N; Miyoshi O; Niikawa N; Sakiyama Y
    Am J Med Genet; 1998 Jan; 75(3):314-7. PubMed ID: 9475605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for human severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; de Saint Basile G; Cavazzana-Calvo M
    Isr Med Assoc J; 2002 Jan; 4(1):51-4. PubMed ID: 11802313
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
    Hershfield MS
    Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.